Wang Feiqian, Numata Kazushi, Nakano Masayuki, Tanabe Mikiko, Chuma Makoto, Nihonmatsu Hiromi, Nozaki Akito, Ogushi Katsuaki, Luo Wen, Ruan Litao, Okada Masahiro, Otani Masako, Inayama Yoshiaki, Maeda Shin
Gastroenterological Center, Yokohama City University Medical Center, Yokohama 232-0024, Japan.
Ultrasound Department, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China.
Diagnostics (Basel). 2020 May 19;10(5):321. doi: 10.3390/diagnostics10050321.
We attempted to establish an ultrasound (US) imaging-diagnostic system for histopathological grades of differentiation of hepatocellular carcinoma (HCC). We conducted a retrospective study of histopathologically confirmed 200 HCCs, classified as early (45 lesions), well- (31 lesions), moderately (68 lesions) or poorly differentiated (diff.) (56 lesions) HCCs. We performed grayscale US to estimate the presence/absence of halo and mosaic signs, Sonazoid contrast-enhanced US (CEUS) to determine vascularity (hypo/iso/hyper) of lesion in arterial and portal phase (PP), and echogenicity of lesion in post-vascular phase (PVP). All findings were of significance for the diagnosis of some (but not all) histological grades < 0.001-0.05). Combined findings with a relatively high diagnostic efficacy for early, poorly and moderately diff. HCC were a combination of absence of halo sign and isoechogenicity in PVP of CEUS (accuracy: 93.0%, AUC: 0.908), hypovascularity in PP (accuracy: 78.0%, area under the curve (AUC): 0.750), and a combination of isovascularity in PP and hypoechogenicity in PVP (accuracy: 75.0%, AUC: 0.739), respectively. On the other hand, neither any individual finding nor any combination of findings yielded an AUC of over 0.657 for the diagnosis of well-diff. HCC. Our study provides encouraging data on Sonazoid CEUS in the histological differential diagnosis of HCC, especially in early HCC, and the effectiveness of this imaging method should be further proved by prospective, large sample, multicenter studies.
我们试图建立一种用于肝细胞癌(HCC)组织病理学分化程度的超声(US)成像诊断系统。我们对200例经组织病理学确诊的HCC进行了回顾性研究,这些病例被分为早期(45个病灶)、高分化(31个病灶)、中分化(68个病灶)或低分化(56个病灶)的HCC。我们进行了灰阶超声检查以评估晕环和镶嵌征的有无,使用声诺维增强超声(CEUS)来确定病灶在动脉期和门静脉期(PP)的血管情况(低/等/高),以及在血管后期(PVP)病灶的回声情况。所有这些发现对于某些(但并非全部)组织学分级的诊断具有重要意义(<0.001 - 0.05)。对于早期、低分化和中分化HCC具有相对较高诊断效能的联合发现分别是:CEUS的PVP中无晕环征且等回声(准确率:93.0%,曲线下面积(AUC):0.908)、PP期低血供(准确率:78.0%,曲线下面积(AUC):0.750),以及PP期等血供和PVP期低回声的联合(准确率:75.0%,AUC:0.739)。另一方面,对于高分化HCC的诊断,无论是单个发现还是任何发现的组合,其AUC均未超过0.657。我们的研究为声诺维CEUS在HCC组织学鉴别诊断中,尤其是早期HCC中的应用提供了令人鼓舞的数据,并且这种成像方法的有效性应通过前瞻性、大样本、多中心研究进一步证实。